InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EFG | Ann: Suspension at close 15/07/11 and Removal fro | 15/07/11 | 0 | 289 | |||
|
|||||||
EFG | Ann: Continuous Disclosure | 15/07/11 | 0 | 265 | |||
|
|||||||
EFG | Ann: EFG Suspension and De-Listing | 12/07/11 | 0 | 305 | |||
|
|||||||
EFG | Ann: Completion of EABB | 08/07/11 | 0 | 271 | |||
|
|||||||
EFG | Ann: Final share buy-back notice - Appendix 3F | 08/07/11 | 0 | 247 | |||
|
|||||||
EFG | Ann: EABB - Reminder of closing time | 06/07/11 | 0 | 143 | |||
|
|||||||
EFG | Ann: EABB Opens | 22/06/11 | 0 | 202 | |||
|
|||||||
EFG | Ann: Completion of MHBB | 15/06/11 | 0 | 130 | |||
|
See All Discussions